DELRAY BEACH, Fla., Jan. 5, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Cell Culture Vessels Market  is projected to grow from about USD 5.10 billionDELRAY BEACH, Fla., Jan. 5, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Cell Culture Vessels Market  is projected to grow from about USD 5.10 billion

Cell Culture Vessels Market worth $8.03 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 5, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Cell Culture Vessels Market  is projected to grow from about USD 5.10 billion in 2025 to USD 8.03 billion by 2030, at a CAGR of 9.5%.

Browse 600 market data Tables and 45 Figures spread through 650 Pages and in-depth TOC on “Cell Culture Vessels Market – Global Forecast to 2030”

Cell Culture Vessels Market Size & Forecast:

  • Market Size Available for Years: 2024–2030
  • 2025 Market Size: USD 5.10 billion
  • 2030 Projected Market Size: USD 8.03 billion
  • CAGR (2025–2030): 9.5%

Cell Culture Vessels Market Trends & Insights:

  • By product, the cell culture vessels market cell factory systems/cell stacks (vessel type) segment is expected to dominate the market in 2024.
  • By application, the biopharmaceutical production segment is projected to grow at the fastest rate from 2025 to 2030.
  • By end user, the pharmaceutical & biotechnology companies’ segment is projected to grow at the fastest rate from 2025 to 2030.
  • The North America cell culture vessels market accounted for a 39.6% revenue share in 2024.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75000041 

The cell culture vessels market is growing rapidly, driven by advancements in biologics, vaccines, and cell and gene therapies, which require efficient and scalable cell expansion platforms. The use of advanced cell culture methods for drug discovery and toxicity testing is therefore increasing demand among research institutes and CROs. Moreover, the shift toward high-density, scalable culture systems, along with increased investments in life sciences R&D, continues to encourage market growth. The growing shift toward more standardized and contamination-controlled vessels is therefore resulting in faster adoption rate. 

Key players are focusing on product innovation in scalable, high-surface-area, single-use cell culture vessels to support biopharmaceutical manufacturing. They are also expanding global manufacturing capacity and distribution networks and strengthening collaborations with biopharma companies and CDMOs to ensure long-term adoption.

By product, the flasks segment is expected to register the fastest growth during the forecast period of 2025 to 2030.

the cell culture vessels market is divided into vessels and accessories. The vessels market is further divided into cell factory systems/cell stacks, roller/roux bottles, flasks, multiwell plates, and Petri dishes. Cell culture flasks are the fastest-growing product segment, driven by their widespread use in routine laboratory work and early-stage research. Their ease of handling, flexibility across multiple cell types, and suitability for small- to mid-scale experiments make them a preferred choice in both academic and industrial settings.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=75000041

By end user, the pharmaceutical & biotechnology companies segment is expected to be the largest segment in the cell culture vessels market.

the market for cell culture vessels has been segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies segment accounts for the largest share of the market in 2024 and is also the fastest-growing end user segment. This dominance is supported by the rise of biologics pipelines, increasing in-house research activity, and the growing need for consistent cell culture systems across discovery, development, and manufacturing workflows.

Asia Pacific is likely to be the fastest growing region in the global cell culture vessels market during the forecast period.

the global cell culture vessels market is divided into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is the fastest-growing region, driven by the rapid expansion of biotech ecosystems, increased research funding, and rising biopharmaceutical production capacity. The region’s growing focus on local drug development, coupled with improving laboratory infrastructure and cost advantages, continues to drive demand for cell culture vessels.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=75000041

Top Companies in Cell Culture Vessels Market:

The Top Companies in Cell Culture Vessels Market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge (Sweden), among others.

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Related Reports:

Cell Culture Market – Global Forecast to 2030

3D Cell Culture Market – Global Forecast to 2030

Cell Based Assays Market – Global Forecast to 2030    

Cell Expansion Market – Global Forecast to 2029

Cell Isolation Market – Global Forecast to 2029

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo – https://mma.prnewswire.com/media/1868219/5701227/MarketsandMarkets_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cell-culture-vessels-market-worth-8-03-billion-by-2030–marketsandmarkets-302652486.html

SOURCE MarketsandMarkets

Market Opportunity
Cellframe Logo
Cellframe Price(CELL)
$0.0922
$0.0922$0.0922
+7.08%
USD
Cellframe (CELL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump’s World Liberty Joins Ripple in Bid for US Banking Charter

Trump’s World Liberty Joins Ripple in Bid for US Banking Charter

The post Trump’s World Liberty Joins Ripple in Bid for US Banking Charter appeared on BitcoinEthereumNews.com. World Liberty Financial (WLFI) became the latest
Share
BitcoinEthereumNews2026/01/09 05:44
Strategic Ethereum Reserves Expand as 67 Organizations Accumulate Millions of ETH

Strategic Ethereum Reserves Expand as 67 Organizations Accumulate Millions of ETH

Ethereum is growing faster than ever as entities keep increasing their ETH holdings and this can be attributed to increased institutional trust in the network.
Share
Blockchainreporter2026/01/09 05:00
IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge!

IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge!

The post IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge! appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 18:00 Discover why BlockDAG’s upcoming Awakening Testnet launch makes it the best crypto to buy today as Story (IP) price jumps to $11.75 and Hyperliquid hits new highs. Recent crypto market numbers show strength but also some limits. The Story (IP) price jump has been sharp, fueled by big buybacks and speculation, yet critics point out that revenue still lags far behind its valuation. The Hyperliquid (HYPE) price looks solid around the mid-$50s after a new all-time high, but questions remain about sustainability once the hype around USDH proposals cools down. So the obvious question is: why chase coins that are either stretched thin or at risk of retracing when you could back a network that’s already proving itself on the ground? That’s where BlockDAG comes in. While other chains are stuck dealing with validator congestion or outages, BlockDAG’s upcoming Awakening Testnet will be stress-testing its EVM-compatible smart chain with real miners before listing. For anyone looking for the best crypto coin to buy, the choice between waiting on fixes or joining live progress feels like an easy one. BlockDAG: Smart Chain Running Before Launch Ethereum continues to wrestle with gas congestion, and Solana is still known for network freezes, yet BlockDAG is already showing a different picture. Its upcoming Awakening Testnet, set to launch on September 25, isn’t just a demo; it’s a live rollout where the chain’s base protocols are being stress-tested with miners connected globally. EVM compatibility is active, account abstraction is built in, and tools like updated vesting contracts and Stratum integration are already functional. Instead of waiting for fixes like other networks, BlockDAG is proving its infrastructure in real time. What makes this even more important is that the technology is operational before the coin even hits exchanges. That…
Share
BitcoinEthereumNews2025/09/18 00:32